Locate Country
Outbreak Surveillance
Clinical Updates
Information that may result in a change in travel advice
Clinical update index
The Beijing Olympics - advice for travellers
Health advice for those attending indoor and outdoor festivals
Health Information Sheets
Foreign and Commonwealth Office
Antarctica and Heard and McDonald Island, South Georgia and South Sandwich Island, French Southern and Antarctic Lands, Bouvet Island
Welcome to the NaTHNaC Country Information page.
The information on this page should be used as part of a comprehensive pre-travel health consultation. Ideally this should be scheduled at least six weeks prior to travel. All travellers should have adequate travel health insurance.
Contents
On this page:
- Recent Clinical Updates
- General Health Risks
- Vaccine Preventable Risks
- Non-Vaccine Preventable Risks
Country Specific Links:
Clinical Updates provide information which may result in a change in travel health advice or practice.
Recent Clinical Updates for this country are listed below:
- There have been no Clinical Updates about this country in the last 6 months.
Some health risks apply to travellers to all countries. Please see below for a list of important health information sheets. A full list of information sheets is available through the Health Information Sheets link on the left hand side of the page.
Health Professionals |
Travellers |
Travellers should be up to date with routinely recommended vaccinations according to the UK schedule:
- NHS Immunisation Information
- Department of Health Immunisation Against Infectious Disease (Green book)
Additional Risks
Travellers should be up to date with routinely recommended vaccinations according to the UK schedule:
- NHS Immunisation Information
- Department of Health Immunisation Against Infectious Disease (Green book)
The diseases below may be a risk in all or part of the country and are presented alphabetically:
Hepatitis B,
Rabies,
Tetanus
HEPATITIS B
Hepatitis B is a viral disease that causes inflammation of the liver and may lead to chronic complications.
Risk assessment
- EpidemiologyInformation on the occurrence of disease within this country - Less than 2% of the population in this country is a carrier of hepatitis B virus (low endemicity).
- ExposureInformation on the mode of transmission and factors that may increase disease risk - Hepatitis B is transmitted via infected blood or bodily fluids. Travellers may be exposed when receiving medical or dental treatment, via direct contact between open skin lesions, or if participating in risk behaviour such as needle sharing, unprotected sex or contact sports. Healthcare workers are at higher risk.
Risk management
- Travellers should avoid contact with blood or bodily fluids. Where contact is unavoidable, appropriate protective precautions should be taken.
- A sterile medical kit should be carried.
- Most travellers are at low risk.
- Vaccine should be givenAll travellers in risk categories should receive vaccine to adult and child travellers at risk due to the nature of their activities or occupation (see above).
- Vaccine should also be givenAll travellers in risk categories should receive vaccine to those with chronic kidney failure, liver disease or haemophilia, injecting drug users, men who have sex with men and individuals who change sexual partners frequently.
Resources
Health ProfessionalsNaTHNaC Health Information Sheet on Hepatitis B Department of Health Immunisation Against Infectious Disease (Green Book) |
Travellers |
RABIES
Rabies is a neurological disease caused by viruses of the Lyssavirus genus.
Risk assessment
- EpidemiologyInformation on the occurrence of disease within this country - This country is presumed to be free of rabies but there is no surveillance reporting.
Risk management
- Travellers should avoid contact with wild or domestic animals. Infections other than rabies can be transmitted through bites.
- Following a bite, wounds should be thoroughly cleansed and a medical assessment sought.
Resources
Health ProfessionalsNaTHNaC Health Information Sheet on Rabies Department of Health. Immunisation against Infectious Disease (Green Book) |
Travellers |
TETANUS
Tetanus is caused by a toxin released from Clostridium tetani bacteria.
Risk assessment
- EpidemiologyInformation on the occurrence of disease within this country - Tetanus bacteria are found worldwide.
- ExposureInformation on the mode of transmission and factors that may increase disease risk - Tetanus bacteria are present in soil and manure and may be introduced through open wounds such as a puncture wound, burn or scratch.
Risk management
- Travellers should thoroughly clean all wounds and seek appropriate medical attention
- Travellers should have completed a primary vaccination course according to the UK schedule.
- A booster dose should be givenAll travellers in risk categories should receive vaccine to travellers whose last dose of a tetanus-containing vaccine was given more than 10 years ago, and who will not have ready access to medical care; even if they have received five doses previously.
Resources
Health ProfessionalsNaTHNaC Health Information Sheet on Tetanus Department of Health Immunisation Against Infectious Disease (Green Book) |
Travellers |
Additional Risks
This section details infectious disease risks for which there are no vaccines as well as some non-infectious disease risks. This is not an exhaustive list. Further information about infectious and non-infectious disease risks can be found on the NaTHNaC Health Information Sheets. Travellers should be aware that accidents and injuries are a cause of serious illness during travel.
The risks below may be a risk in all or part of the country and are presented alphabetically:
Altitude
ALTITUDE
There is a point of elevation in this country higher than 2,500 metres (m).
Risk assessment
- Travel to destinations of 2,500-3,500 m (8,200-11,500 feet) or higher carries the risk of altitude illness. Important risk factors for altitude illness are the altitude gained, rate of ascent and sleeping altitude. Rapid ascent without a period of acclimatisation puts a traveller at higher risk.
Risk management
- The most important prevention measure is adequate acclimatisation.
- Travellers should spend a few days at an intermediate altitude below 3,000 m.
- Ascent above 3,000 m should be gradual with no more than a 300 - 500 m increase in sleeping altitude per day, with a rest day every three days.
- Acetazolamide is recognised for use in the prevention of altitude illness. It should not replace acclimatisation and gradual ascent.
- Travellers who develop symptoms of altitude illness (headache, fatigue, loss of appetite, nausea and sleep disturbance) should avoid further ascent. In the absence of improvement or with progression of symptoms the first response should be to descend.
- Development of more severe forms of altitude illness, high-altitude cerebral oedema (HACE) (confusion, difficulty with balance and coordination) or high-altitude pulmonary oedema (HAPE) (shortness of breath at rest, cough and chest tightness), require immediate descent and emergency medical treatment.
Resources
The travel health information contained in these pages is intended for health professionals who assess a patients travel health needs. This document is not a complete medical guide for travellers and as such travellers using this site should consult with a health professional for specific information related to your travel and medical history. While every care has been taken to ensure the accuracy and timeliness of the travel health information, NaTHNaC cannot accept any liability for injury, loss or damage arising in any respect of any statement contained therein.
For the purpose of these web pages the term "country" covers countries, territories and areas. Areas within a country may be shown separately where it is felt necessary in order to provide travel health information.
Disclaimer | Copyright | Privacy | Sitemap | Accessibility


